{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:45:33Z","timestamp":1790063133571,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40123-024-01065-z","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:37:24Z","timestamp":1732034244000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pooled Multicenter Safety Analysis of Lupin\u2019s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-7882","authenticated-orcid":false,"given":"Debdulal","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar Kanti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angshuman","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptorshi","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranabir","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"1065_CR1","unstructured":"World Population Ageing 2023: Challenges and opportunities of population ageing in the least developed countries. UN DESA\/\u00a0POP\/2023\/TR\/NO.5."},{"issue":"2","key":"1065_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1. (Epub 2014 Jan 3).","journal-title":"Lancet Glob Health"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2018.11.002","volume":"19","author":"P Jaki Mekjavi\u0107","year":"2019","unstructured":"Jaki Mekjavi\u0107 P, J\u016brat\u0117 Bal\u010di\u016bnien\u0117 V, \u0106ekli\u0107 L, Ernest J, Jamrichova Z, Zsolt Nagy Z, Petkova I, Teper S, Garda\u0161evi\u0107 Top\u010di\u0107 I, Veith M. The burden of macular diseases in Central and Eastern Europe-implications for healthcare systems. Value Health Reg Issues. 2019;19:1\u20136. https:\/\/doi.org\/10.1016\/j.vhri.2018.11.002. (Epub 2019 Jan 8).","journal-title":"Value Health Reg Issues"},{"issue":"14","key":"1065_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2415-14-78","volume":"12","author":"SR Dawson","year":"2014","unstructured":"Dawson SR, Mallen CD, Gouldstone MB, Yarham R, Mansell G. The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol. 2014;12(14):78. https:\/\/doi.org\/10.1186\/1471-2415-14-78.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"1065_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"30","author":"R Lee","year":"2015","unstructured":"Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;30(2):17. https:\/\/doi.org\/10.1186\/s40662-015-0026-2.","journal-title":"Eye Vis (Lond)"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2016.05.023","volume":"170","author":"MW Stewart","year":"2016","unstructured":"Stewart MW, Narayanan R, Gupta V, Rosenfeld PJ, Martin DF, Chakravarthy U. Counterfeit Avastin in India: punish the criminals, not the patients. Am J Ophthalmol. 2016;170:228\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.023. (Epub 2016 Jun 7).","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"1065_CR7","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2147\/OPTH.S180393","volume":"24","author":"A Sharma","year":"2018","unstructured":"Sharma A, Reddy P, Kuppermann BD, Bandello F, Lowenstein A. Biosimilars in ophthalmology: \u201cIs there a big change on the horizon?\u201d Clin Ophthalmol. 2018;24(12):2137\u201343. https:\/\/doi.org\/10.2147\/OPTH.S180393.","journal-title":"Clin Ophthalmol"},{"key":"1065_CR8","doi-asserted-by":"publisher","unstructured":"Yanagi Y, Takahashi K, Iida T, Gomi F, Morii J, Kunikane E, Sakamoto T. Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration in Japan. Ophthalmol Ther. 2023;12(4):2005\u201321. https:\/\/doi.org\/10.1007\/s40123-023-00715-y. Epub 2023 May 12. Erratum in: Ophthalmol Ther. 2023;12(5):2821\u20132822. https:\/\/doi.org\/10.1007\/s40123-023-00788-9.","DOI":"10.1007\/s40123-023-00715-y 10.1007\/s40123-023-00788-9"},{"issue":"8","key":"1065_CR9","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.4103\/ijo.IJO_2118_21","volume":"70","author":"R Singh","year":"2022","unstructured":"Singh R, Chauhan R, Saxena A, Shah A, Mondal L, Bakhle D, Shah C, Shah A, Deoghare S, Krishnan N, Godse N. A prospective, randomized, parallel group, double-blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin\u2019s ranibizumab with Lucentis\u00ae in patients with neovascular age-related macular degeneration. Indian J Ophthalmol. 2022;70(8):3008\u201314. https:\/\/doi.org\/10.4103\/ijo.IJO_2118_21.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1065_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/23258160-20140306-08","volume":"45","author":"JB Fileta","year":"2014","unstructured":"Fileta JB, Scott IU, Flynn HW. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2014;45(2):143\u20139. https:\/\/doi.org\/10.3928\/23258160-20140306-08.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"1065_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233595","volume":"15","author":"P Mitchell","year":"2020","unstructured":"Mitchell P, Sheidow TG, Farah ME, Mahmood S, Minnella AM, Eter N, Eldem B, Al-Dhibi H, Macfadden W, Parikh S, Dunger-Baldauf C, Mahgoub MM, Schmidt-Erfurth U, LUMINOUS study investigators. Effectiveness and safety of ranibizumab 05 mg in treatment-na\u00efve patients with diabetic macular edema: results from the real-world global LUMINOUS study. PLoS ONE. 2020;15(6): e0233595. https:\/\/doi.org\/10.1371\/journal.pone.0233595.","journal-title":"PLoS ONE"},{"key":"1065_CR12","first-page":"142","volume":"112","author":"D Sarraf","year":"2014","unstructured":"Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014;112:142\u201359.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"8","key":"1065_CR13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/Iae.0000000000001142","volume":"36","author":"LN Kim","year":"2016","unstructured":"Kim LN, Mehta H, Barthelmes D, Nguyen V, Gillies MC. Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina. 2016;36(8):1418\u201331. https:\/\/doi.org\/10.1097\/Iae.0000000000001142.","journal-title":"Retina"},{"issue":"10","key":"1065_CR14","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4103\/ijo.IJO_1866_19","volume":"68","author":"A Kelkar","year":"2020","unstructured":"Kelkar A, Webers C, Shetty R, Kelkar J, Labhsetwar N, Pandit A, Malode M, Tidke S. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema. Indian J Ophthalmol. 2020;68(10):2143\u20137. https:\/\/doi.org\/10.4103\/ijo.IJO_1866_19.","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"1065_CR15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","volume":"119","author":"DF Martin","year":"2012","unstructured":"Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388\u201398. https:\/\/doi.org\/10.1016\/j.ophtha.2012.03.053. (Epub 2012 May 1).","journal-title":"Ophthalmology"},{"issue":"10","key":"1065_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/archophthalmol.2010.223","volume":"128","author":"LH Curtis","year":"2010","unstructured":"Curtis LH, Hammill BG, Schulman KA, Cousins SW. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol. 2010;128(10):1273\u20139. https:\/\/doi.org\/10.1001\/archophthalmol.2010.223. (Erratum in: Arch Ophthalmol. 2010 Dec;128(12):1623).","journal-title":"Arch Ophthalmol"},{"key":"1065_CR17","doi-asserted-by":"publisher","unstructured":"Sharma S, RE-ENACT 2 Study Investigators Group, Khan M, Chaturvedi A. A Multicenter, Retrospective Study (RE-ENACT2) on Razumab\u2122 (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion. Ophthalmol Ther. 2020;9(3):625\u201339. https:\/\/doi.org\/10.1007\/s40123-020-00277-3. (Epub 2020 Jul 2)","DOI":"10.1007\/s40123-020-00277-3"},{"issue":"9","key":"1065_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.oret.2023.05.005","volume":"7","author":"A Loewenstein","year":"2023","unstructured":"Loewenstein A, Czumbel N, Ernest J, Dusov\u00e1 J, Pearlman J, Nowosielska A. Randomized trial of biosimilar XSB-001 versus reference ranibizumab in patients with neovascular age-related macular degeneration. Ophthalmol Retina. 2023;7(9):753\u201361. https:\/\/doi.org\/10.1016\/j.oret.2023.05.005. (Epub 2023 May 11).","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"1065_CR19","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1038\/s41598-020-70269-7","volume":"10","author":"VA de Vries","year":"2020","unstructured":"de Vries VA, Bassil FL, Ramdas WD. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):13248. https:\/\/doi.org\/10.1038\/s41598-020-70269-7.","journal-title":"Sci Rep"},{"issue":"6 (Suppl)","key":"1065_CR20","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.jval.2023.03.614","volume":"26","author":"I Keady","year":"2023","unstructured":"Keady I, Rickard Q, Xin L, Morris M, Thomas G, Foxon G. EE313 Utilisation of the cost-saving impact of biosimilar switching in ophthalmological diseases in the NHS: a case-study for a ranibizumab biosimilar. Value Health. 2023;26(6 (Suppl)):S116. https:\/\/doi.org\/10.1016\/j.jval.2023.03.614.","journal-title":"Value Health"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01065-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T15:04:32Z","timestamp":1736607872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01065-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors, including Dr. Debdulal Chakraborty, Dr. Tushar Kanti Sinha, Dr. Sourav Sinha, Dr. Aniruddha Maiti, Dr. Angshuman Mukherjee, Dr. Krishnendu Nandi, Dr. Sudipta Das, Dr. Saptorshi Majumdar, Dr. Dinesh Rungta, and Mr. Ranabir Bhattacharya, have no conflicts of interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Disha Eye Hospitals in Kolkata, (Regn Number ECR\/846\/Inst\/WB\/2016\/RR-19: EC-CT-2024-133). Patient consent was obtained for the use of their data for research purposes, and this report does not contain any personal identifying information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}